These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23072735)

  • 1. Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.
    Usami Y; Kobayashi Y; Kameda T; Miyazaki A; Matsuda K; Sugano M; Kawasaki K; Kurihara Y; Kasama T; Tozuka M
    Biosci Rep; 2012 Dec; 33(1):49-56. PubMed ID: 23072735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of novel truncated apolipoprotein A-I in human high-density lipoprotein generated by sequential treatment with myeloperoxidase and chymase.
    Lai SJ; Kameda T; Morita M; Yamagata Y; Nishizaka K; Horiuchi Y; Kobayashi Y; Usami Y; Liu JJ; Kasama T; Tozuka M; Ohkawa R
    Biochimie; 2024 Mar; 218():34-45. PubMed ID: 37774825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.
    Usami Y; Matsuda K; Sugano M; Ishimine N; Kurihara Y; Sumida T; Yamauchi K; Tozuka M
    J Immunol Methods; 2011 Jun; 369(1-2):51-8. PubMed ID: 21497162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr
    Kareinen I; Baumann M; Nguyen SD; Maaninka K; Anisimov A; Tozuka M; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    J Lipid Res; 2018 Jun; 59(6):945-957. PubMed ID: 29581158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
    Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.
    Lee M; Kovanen PT; Tedeschi G; Oungre E; Franceschini G; Calabresi L
    J Lipid Res; 2003 Mar; 44(3):539-46. PubMed ID: 12562834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
    Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
    J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14.
    Park JH; Park SM; Park KH; Cho KH; Lee ST
    Biochem Biophys Res Commun; 2011 May; 409(1):58-63. PubMed ID: 21549099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo.
    Maafi F; Li B; Gebhard C; Brodeur MR; Nachar W; Villeneuve L; Lesage F; Rhainds D; Rhéaume E; Tardif JC
    Atherosclerosis; 2017 Mar; 258():8-19. PubMed ID: 28167355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.
    DiDonato JA; Aulak K; Huang Y; Wagner M; Gerstenecker G; Topbas C; Gogonea V; DiDonato AJ; Tang WHW; Mehl RA; Fox PL; Plow EF; Smith JD; Fisher EA; Hazen SL
    J Biol Chem; 2014 Apr; 289(15):10276-10292. PubMed ID: 24558038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
    Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW
    J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteolytic method for distinguishing between lipid-free and lipid-bound apolipoprotein A-I.
    Safi W; Maiorano JN; Davidson WS
    J Lipid Res; 2001 May; 42(5):864-72. PubMed ID: 11352994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A.
    Kokkonen JO; Vartiainen M; Kovanen PT
    J Biol Chem; 1986 Dec; 261(34):16067-72. PubMed ID: 3536921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
    Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
    FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
    Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity.
    Dinnes DL; White MY; Kockx M; Traini M; Hsieh V; Kim MJ; Hou L; Jessup W; Rye KA; Thaysen-Andersen M; Cordwell SJ; Kritharides L
    FASEB J; 2016 Dec; 30(12):4239-4255. PubMed ID: 27630170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
    Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
    J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M; Makrides SC; Jonas A; Zannis VI
    J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.